Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanislav Henkin

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Journal of Thrombosis and Haemostasis : JTH|October 21, 2019
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trialRobert D McBane, Waldemar E Wysokinski, Jennifer G Le-Rademacher, et al.
Journal of the American College of Radiology : JACR|March 20, 2026
ACR Appropriateness Criteria® Suspected and Known Renal or Splanchnic Artery Aneurysm, Sasan Partovi, Xin Li, et al.
JAMA Network Open|June 22, 2022
Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity RevascularizationConnie N Hess, Michael Szarek, Sonia S Anand, et al.
Journal of Thrombosis and Haemostasis : JTH|March 27, 2024
Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trialRobert D McBane, Charles L Loprinzi, Tyler Zemla, et al.
Journal of the American Heart Association|March 27, 2024
Posttraumatic Stress Disorder After Spontaneous Coronary Artery Dissection: A Report of the International Spontaneous Coronary Artery Dissection RegistryJennifer A Sumner, Esther S H Kim, Malissa J Wood, et al.
Journal of Thrombosis and Haemostasis : JTH|December 21, 2024
Corrigendum to 'Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial': [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714]Robert D McBane, Charles L Loprinzi, Tyler Zemla, et al.
BMC Cardiovascular Disorders|April 18, 2026
Factors associated with a complicated hospital course in patients with spontaneous coronary artery dissection: a report of the iSCAD registryFahad Alkhalfan, Malissa Wood, Katherine Leon, et al.
JAMA Cardiology|March 29, 2026
Pregnancy-Associated Spontaneous Coronary Artery Dissection: A Report of the iSCAD RegistryAgnes Koczo, Anna Grodzinsky, Esther S H Kim, et al.
American Heart Journal Plus : Cardiology Research and Practice|May 27, 2026
Patient characteristics and incidence of in-hospital events in spontaneous coronary artery dissection and suspected concurrent Takotsubo syndrome: A report of the iSCAD registryGerald Chi, Esther S H Kim, Heather L Gornik, et al.
Vascular Medicine (London, England)|June 20, 2024
Migraine headache in patients with spontaneous coronary artery dissection: A report of the iSCAD RegistryBryan J Wells, Malissa J Wood, Anne E O'Duffy, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Journal of Thrombosis and Haemostasis : JTH|October 21, 2019
Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trialRobert D McBane, Waldemar E Wysokinski, Jennifer G Le-Rademacher, et al.
Journal of the American College of Radiology : JACR|March 20, 2026
ACR Appropriateness Criteria® Suspected and Known Renal or Splanchnic Artery Aneurysm, Sasan Partovi, Xin Li, et al.
JAMA Network Open|June 22, 2022
Rivaroxaban and Risk of Venous Thromboembolism in Patients With Symptomatic Peripheral Artery Disease After Lower Extremity RevascularizationConnie N Hess, Michael Szarek, Sonia S Anand, et al.
Journal of Thrombosis and Haemostasis : JTH|March 27, 2024
Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trialRobert D McBane, Charles L Loprinzi, Tyler Zemla, et al.
Journal of the American Heart Association|March 27, 2024
Posttraumatic Stress Disorder After Spontaneous Coronary Artery Dissection: A Report of the International Spontaneous Coronary Artery Dissection RegistryJennifer A Sumner, Esther S H Kim, Malissa J Wood, et al.
Journal of Thrombosis and Haemostasis : JTH|December 21, 2024
Corrigendum to 'Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial': [Journal of Thrombosis and Haemostasis Volume 22, Issue 6, June 2024, Pages 1704-1714]Robert D McBane, Charles L Loprinzi, Tyler Zemla, et al.
BMC Cardiovascular Disorders|April 18, 2026
Factors associated with a complicated hospital course in patients with spontaneous coronary artery dissection: a report of the iSCAD registryFahad Alkhalfan, Malissa Wood, Katherine Leon, et al.
JAMA Cardiology|March 29, 2026
Pregnancy-Associated Spontaneous Coronary Artery Dissection: A Report of the iSCAD RegistryAgnes Koczo, Anna Grodzinsky, Esther S H Kim, et al.
American Heart Journal Plus : Cardiology Research and Practice|May 27, 2026
Patient characteristics and incidence of in-hospital events in spontaneous coronary artery dissection and suspected concurrent Takotsubo syndrome: A report of the iSCAD registryGerald Chi, Esther S H Kim, Heather L Gornik, et al.
Vascular Medicine (London, England)|June 20, 2024
Migraine headache in patients with spontaneous coronary artery dissection: A report of the iSCAD RegistryBryan J Wells, Malissa J Wood, Anne E O'Duffy, et al.
Pageof 9